2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid

C66H111N13O15S — CID 123185847

IUPAC2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid
SMILESCCC1NC(=O)C(C(O)C(C)Cc2nc3ccc(S(=O)(=O)O)cc3[nH]2)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(C(C)C)NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O
InChIInChI=1S/C66H111N13O15S/c1-24-44-62(87)73(17)33-52(80)74(18)47(27-34(2)3)59(84)72-53(38(10)11)65(90)75(19)48(28-35(4)5)58(83)67-41(15)57(82)68-42(16)61(86)76(20)49(29-36(6)7)63(88)77(21)50(30-37(8)9)64(89)78(22)54(39(12)13)66(91)79(23)55(60(85)71-44)56(81)40(14)31-51-69-45-26-25-43(95(92,93)94)32-46(45)70-51/h25-26,32,34-42,44,47-50,53-56,81H,24,27-31,33H2,1-23H3,(H,67,83)(H,68,82)(H,69,70)(H,71,85)(H,72,84)(H,92,93,94)
InChIKeyBJWRYKXRHFFNLQ-UHFFFAOYSA-N
MW1358.76 g/mol
LogP2.67
Rot. Bonds16

About 2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid

2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid (PubChem CID 123185847) has the molecular formula C66H111N13O15S and a molecular weight of 1358.76 g/mol. Its IUPAC name is 2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid.

Molecular Properties

Compound Name2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid
PubChem CID123185847
Molecular FormulaC66H111N13O15S
Molecular Weight1358.76 g/mol
Exact Mass1357.80
IUPAC Name2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid
SMILESCCC1NC(=O)C(C(O)C(C)Cc2nc3ccc(S(=O)(=O)O)cc3[nH]2)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(C(C)C)NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O
InChIInChI=1S/C66H111N13O15S/c1-24-44-62(87)73(17)33-52(80)74(18)47(27-34(2)3)59(84)72-53(38(10)11)65(90)75(19)48(28-35(4)5)58(83)67-41(15)57(82)68-42(16)61(86)76(20)49(29-36(6)7)63(88)77(21)50(30-37(8)9)64(89)78(22)54(39(12)13)66(91)79(23)55(60(85)71-44)56(81)40(14)31-51-69-45-26-25-43(95(92,93)94)32-46(45)70-51/h25-26,32,34-42,44,47-50,53-56,81H,24,27-31,33H2,1-23H3,(H,67,83)(H,68,82)(H,69,70)(H,71,85)(H,72,84)(H,92,93,94)
InChIKeyBJWRYKXRHFFNLQ-UHFFFAOYSA-N
XLogP2.67
TPSA361.85 Ų
H-Bond Donors7
H-Bond Acceptors15
Rotatable Bonds16
Heavy Atoms95
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001358.76
LogP ≤ 52.67
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Sulfonic_acid_2', 'substructure': 'N/A'}

Analyze 2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid?
The IUPAC name of 2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid (CID 123185847) is 2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid.
What is the SMILES notation for 2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid?
The canonical SMILES for 2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid is CCC1NC(=O)C(C(O)C(C)Cc2nc3ccc(S(=O)(=O)O)cc3[nH]2)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(C(C)C)NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O.
What is the InChIKey of 2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid?
The InChIKey is BJWRYKXRHFFNLQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C66H111N13O15S/c1-24-44-62(87)73(17)33-52(80)74(18)47(27-34(2)3)59(84)72-53(38(10)11)65(90)75(19)48(28-35(4)5)58(83)67-41(15)57(82)68-42(16)61(86)76(20)49(29-36(6)7)63(88)77(21)50(30-37(8)9)64(89)78(22)54(39(12)13)66(91)79(23)55(60(85)71-44)56(81)40(14)31-51-69-45-26-25-43(95(92,93)94)32-46(45)70-51/h25-26,32,34-42,44,47-50,53-56,81H,24,27-31,33H2,1-23H3,(H,67,83)(H,68,82)(H,69,70)(H,71,85)(H,72,84)(H,92,93,94).
What are the key properties of 2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid?
2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid has a molecular weight of 1358.76 g/mol, XLogP of 2.67, 16 rotatable bonds, 7 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[5-ethyl-1,7,10,16,20,23,25,28,31-nonamethyl-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-3-hydroxy-2-methylpropyl]-3H-benzimidazole-5-sulfonic acid is sourced from PubChem (CID 123185847), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).